GutCRINE
Latest round
- Seed
Last raised
- Apr 2023
Total raised
- $0.6M
Investors
- 2
About GutCRINE
Founded in 2023 and based in Denmark, Gutcrine ApS is a spinout company from the University of Copenhagen that develops drugs to treat neurological and metabolic conditions. Oluf Borbye Pedersen is the founder of the company. The company is developing a therapy targeting metabolic and age-related diseases like obesity, type 2 diabetes, osteoporosis, and Parkinson’s disease.
Who invested in GutCRINE
2 investors across 1 round
See all investors in GutCRINE
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 11, 2023
Amount
$0.6M
Investors
Questions about GutCRINE
Who invested in GutCRINE?
GutCRINE has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GutCRINE raised?
GutCRINE has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GutCRINE last raise money?
GutCRINE's most recent round on record is a Seed, in Apr 2023.
What does GutCRINE do?
Founded in 2023 and based in Denmark, Gutcrine ApS is a spinout company from the University of Copenhagen that develops drugs to treat neurological and metabolic conditions.
Where is GutCRINE headquartered?
GutCRINE is headquartered in Denmark.
Which VCs invest in companies like GutCRINE?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at GutCRINE's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like GutCRINE? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.